Assignee
IMCHECK THERAPEUTICS SAS
FR·5 granted patents·3 pending applications·0 citations·filing 2018–2023
Top patents by PatentIndex Score
8 records- 0178US11945871B2Anti-BTN3A antibodies and their use in treating cancer or infectious disordersIMCHECK THERAPEUTICS SAS·Filed 2023·Granted Apr 2, 2024·0 cites·14 claims
- 0269US11987631B2Anti-BTN3A antibodies and their use in treating cancer or infectious disordersIMCHECK THERAPEUTICS SAS·Filed 2019·Granted May 21, 2024·0 cites·14 claims
- 0368US2023272080A1Anti-btn3a antibodies and their use in treating cancer or infectious disordersIMCHECK THERAPEUTICS SAS·Filed 2022·Application pending·0 cites
- 0468US2024117041A1Antibodies having specificity for btn2 and uses thereofIMCHECK THERAPEUTICS SAS·Filed 2022·Application pending·0 cites
- 0558US12247075B2BTN3A binding proteins and uses thereofIMCHECK THERAPEUTICS SAS·Filed 2019·Granted Mar 11, 2025·0 cites·9 claims
- 0658US11572409B2Antibodies having specificity for BTN2 and uses thereofIMCHECK THERAPEUTICS SAS·Filed 2018·Granted Feb 7, 2023·0 cites·6 claims
- 0753US2023227558A1Selection of responders for anti-btn3a treatmentIMCHECK THERAPEUTICS SAS·Filed 2023·Application pending·0 cites
- 0842US12258400B2Antibodies having specificity for BTN2 and uses thereofIMCHECK THERAPEUTICS SAS·Filed 2020·Granted Mar 25, 2025·0 cites·14 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →